Brief: A Hong Kong-Based Activist Hedge Fund Is Pushing Torii Pharmaceuticals To Ban Accepting Execs From Parent Japan Tobacco - Nikkei
Jan 22 (Reuters) - Nikkei:
* A HONG KONG-BASED ACTIVIST HEDGE FUND IS PUSHING DRUGMAKER
TORII
PHARMACEUTICALS TO BAN ACCEPTING EXECUTIVES FROM PARENT JAPAN
TOBACCO - NIKKEI
* TORII CONFIRMED THAT IT HAS RECEIVED SHAREHOLDER PROPOSALS
AHEAD
OF ITS GENERAL MEETING IN MARCH - NIKKEI
* TORII SAID IT PLANS TO ACCESS THE PROPOSALS AND RELEASE
ITS
DECISION ALONGSIDE FISCAL 2021 EARNINGS AFTER A BOARD MEETING IN
FEBRUARY - NIKKEI
Further company coverage: 4551.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)